MedTrace Logo

A Game-based Neurodevelopmental Assessment for Young Children

NCT05780853 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 590

Last updated 2024-07-25

No results posted yet for this study

Summary

The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old.

The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool.

The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.

All participants will complete the tablet game-based assessment which aims to assess a range of neuropsychological functions including attention, memory, language, motor, executive functions and social-emotional skills. Parents/carers of participants will also complete a demographic questionnaire and the Adaptive Behaviour System - Third Edition (ABAS-3), which is a questionnaire that assesses a child's development. Some participants will be re-tested on the tablet game-based assessment approximately 2 weeks after the first tablet game-based assessment to ensure the game's validity.

Conditions

  • Neurodevelopmental Disorders
  • Autism Spectrum Disorder
  • Attention Deficit Hyperactivity Disorder
  • Dyslexia
  • Specific Learning Disorder
  • Child Development

Interventions

DIAGNOSTIC_TEST

Tablet Game-based Assessment - YARN assessment service

Tablet game-based assessment to assess neurodevelopmental profile.

DIAGNOSTIC_TEST

Adaptive Behavior Assessment System, Third Edition (ABAS-3)

A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.

OTHER

Demographic questionnaire

Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.

Sponsors & Collaborators

  • Brightlobe Limited

    lead INDUSTRY

Principal Investigators

  • Jane Iles, PhD DClinPsy · Brightlobe Limited

Eligibility

Min Age
3 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05780853 on ClinicalTrials.gov